ISO-1-MIF-Antagonist-DataSheet-生命科学试剂-MedChemExpress_第1页
ISO-1-MIF-Antagonist-DataSheet-生命科学试剂-MedChemExpress_第2页
ISO-1-MIF-Antagonist-DataSheet-生命科学试剂-MedChemExpress_第3页
ISO-1-MIF-Antagonist-DataSheet-生命科学试剂-MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEISO-1Cat. No.: HY-16692CAS No.: 478336-92-4Synonyms: MIF Antagonist分式: CHNO分量: 235.24作靶点: Others作通路: Others储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 36 mg/mL (153.04 mM)* means solubl

2、e, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 4.2510 mL 21.2549 mL 42.5098 mL5 mM 0.8502 mL 4.2510 mL 8.5020 mL10 mM 0.4251 mL 2.1255 mL 4.2510 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY物活性 ISO-1巨噬细胞移动抑制因(MIF) 拮抗剂,IC50 值为 7 M。IC50 & Target IC50:

3、7M (MIF) 1体外研究ISO-1 (0.1-20 M; 16 hours) has a slight inhibitory effect on Cox-2 secretion without the addition of1/3 Master of Small Molecules 您边的抑制剂师www.MedChemErecombinant MIF 1.Western Blot Analysis 1Cell Line: RAW 264.7 macrophage cellsConcentration: 0.1M,1M,10M,20MIncubation Time: 16 hoursResu

4、lt: Suppressed Cox-2 secretion.体内研究 ISO-1 (injected intraperitoneally; 3.5-35 mg/kg; twice daily; 2 weeks) improves the survival rate from lethalendotoxemia and shows the anti-inflammatory effect 2.ISO-1 (intraperitoneal injection; 35 mg/kg; twicedaily; 3 days) causes a significant reduction in aver

5、age implant size and decreases Flk1 expression inimplants 3.Animal Model: C57Bl/6 MIF+/+ and MIF/ mice 2Dosage: 3.5-35 mg/kgAdministration: Injected intraperitoneally; 3.5-35 mg/kg; twice a day ; 2 weeksResult: Was protective against lethal sepsis.Animal Model: Female C57BL/6-Tg(ACTB-EGFP)1Osb/J mic

6、e 3Dosage: 35 mg/kgAdministration: Intraperitoneal injection; 35 mg/kg; twice daily; 3 daysResult: Reduced average endometriotic implant size.户使本产品发表的科研献 J Neuroinflammation. 2018 Oct 19;15(1):291. Mol Med Rep. 2019 Jul 9.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Lubetsky

7、 JB, et al. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J Biol Chem. 2002 Jul 12;277(28):24976-82.2. Al-Abed Y, et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory ac

8、tivity and increases survival in severesepsis. J Biol Chem. 2005 Nov 4;280(44):36541-4.2/3 Master of Small Molecules 您边的抑制剂师www.MedChemE3. Nothnick WB, et al. Inhibition of macrophage migration inhibitory factor reduces endometriotic implant size in mice with experimentallyinduced disease. J Endometr. 2011 Sep 30;3(3):135-142.McePdfHeightCaution: Product has not been fully validated for medical applicatio

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论